Trial intelligence / Profile preview

Stimulated intrauterine insemination versus expectant management for unexplained infertility

ACTRN12612001025820Phase 4Completed

Sponsor
The University of Auckland
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of clomiphene in Unexplained infertility (2 arms), sponsored by The University of Auckland. Primary endpoint: Cumulative live birth rate. Started Mar 2013; status: completed.

02

Drugs

clomiphene
03

Conditions

Unexplained infertility

Beyond the preview

Go deeper on ACTRN12612001025820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612001025820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call